<DOC>
	<DOC>NCT01648283</DOC>
	<brief_summary>This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes methadone.</brief_summary>
	<brief_title>CYP2B6 Polymorphisms in Methadone</brief_title>
	<detailed_description />
	<mesh_term>Methadone</mesh_term>
	<criteria>Each subject must meet all of the following criteria: 1850 yr old CYP2B6*1/*1, CYP2B6*1/*6 or CYP2B6*6/*6 genotype Good general health with no remarkable medical conditions BMI &lt; 33 Provided informed consent Subjects will not be enrolled if any of the following criteria exist: Known history of liver or kidney disease Use of prescription or non prescription medications, herbals or foods known to be metabolized by or affect CYP2B6 Females who are pregnant or nursing Known history of drug or alcohol addiction (prior or present addiction or treatment for addiction) Direct physical access to and routine handling of addicting drugs in the regular course of duty (this is a routine exclusion from studies of drugs with addiction potential)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>methadone polymorphisms</keyword>
</DOC>